ACADIA Pharmaceuticals Earnings & Forecasts

ACADIA Pharmaceuticals (ACAD) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Aug 4, 2026	$0.18	$0.04	350.0 %
Q1	May 6, 2026	$0.02	$0.07	-71.4 %
Q4	Feb 25, 2026	$0.14	$0.13	7.69 %
Q3	Nov 5, 2025	$0.26	$0.14	85.7 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Aug 4, 2026	$307.96M	$295.22M	4.31 %
Q1	May 6, 2026	$268.06M	$280.65M	-4.48 %
Q4	Feb 25, 2026	$283.99M	$292.52M	-2.92 %
Q3	Nov 5, 2025	$278.63M	$275.36M	1.19 %

ACADIA Pharmaceuticals Guidance

ACADIA Pharmaceuticals (ACAD)는 8월 4, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $1.24B - $1.3B 범위로 예상했습니다.

이전 가이던스와 비교하여 ACADIA Pharmaceuticals는 매출 전망치를 이전 범위인 상향 조정됨에서 $1.22B - $1.28B로 상향 조정했습니다.

ACADIA Pharmaceuticals은 15과 11월 2, 2022 사이에 8월 4, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 6 times and lowered it 2 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.04	$0.07	$0.13	$0.14
Actual	$0.18	$0.02	$0.14	$0.26
Surprise	+350.0%	-71.4%	+7.69%	+85.7%
Revenue
Estimate	$295.2M	$280.6M	$292.5M	$275.4M
Actual	$308.0M	$268.1M	$284.0M	$278.6M
Surprise	+4.31%	-4.48%	-2.92%	+1.19%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.19	$0.22	$0.18	$0.20
Revenue
Consensus	$332.4M	$363.4M	—	—

More with Benzinga EdgeGet Access

ACADIA Pharmaceuticals Inc